Translational Neural Devices (R61/R33 - Clinical Trial Optional)
This grant funds the development of translational neural devices for clinical applications.
About this program
The Translational Neural Devices grant program supports innovative research aimed at developing neural devices that can be translated into clinical practice. This program is designed for researchers and institutions focused on advancing the field of neuroscience through the creation of devices that can improve patient outcomes. The grant allows for clinical trial optional phases, providing flexibility in research design and implementation. Eligible applicants include academic institutions, nonprofit organizations, and small businesses engaged in neuroscience research. The program encourages collaboration between researchers and clinical practitioners to ensure that the developed devices meet real-world clinical needs. By funding projects that bridge the gap between laboratory research and clinical application, this grant aims to foster advancements in neural technology that can significantly impact healthcare.
Eligibility
Academic institutions, nonprofit organizations, small businesses engaged in neuroscience research.